The South-East Asia has been free of wild poliovirus since 2011. In order to maintain this status and keep the population protected countries must ensure that population immunity remains high; through
Access to affordable vaccines of assured quality is central to the performance of immunization programmes. A positive enabling environment for vaccine development requires longer-term strategies, sign
